Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Point-of-Care Diagnostic Device Performs Several Tests from a Single Sample Preparation

By LabMedica International staff writers
Posted on 12 May 2015
A prototype model of a portable multipurpose point-of-care diagnostic analyzer was used in proof-of-principle studies that established the potential usefulness of this type of instrument.

Most instruments for point-of-care testing were designed for a single purpose such as measuring blood glucose or for home pregnancy detection, requiring clinics to purchase numerous devices to cover the range of diagnostic tests to be performed. More...
While these tests are simple to perform individually, each device often has a different sample preparation procedure that must be performed for each test. Having different sample preparation procedures for each diagnostic test increases the time to perform several tests, as samples must be prepared separately, and increases the chance of error due to improper sample preparation.

A new device, developed at Emory University (Atlanta, GA, USA) eliminates the problem of different preparation procedures by combining several point-of-care applications into a single, easy-to-use device with a common method of sample preparation.

The "AcµRay" system consists of a small diagnostic device that can be connected to a computer through a USB port. Diagnostic tests are performed by plugging a sensor into the device, then passing a blood sample through the detector. The attached computer analyzes and reports the results of the test. The sensors comprise a small microchip that can be coated with different antibodies that detect selected biomarkers. Biomarker binding to the antibodies on the chip changes its acoustic signature, which is detected by the detector and interpreted by the computer. Various diagnostics tests can be carried out by the AcµRay device by simply unplugging one sensor and plugging in a new one.

So far, a prototype of the AcµRay instrument has been built, and a proof-of-principle study was successfully carried out in which the acoustic sensor employed a biomarker for mesothelioma, a rare form of cancer linked to asbestos exposure.

Related Links:

Emory University



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.